Technical Analysis
Comprehensive insights into market trends, chart patterns, and key indicators. Equip yourself with the tools and strategies to make data-driven trading decisions.
European healthcare stocks face 2025 uncertainties from US policy changes and key drug trial results. Investor focus is on US political developments and potential impacts on leading European pharma companies reliant on the American market.
European Healthcare Stocks Face US Policy and Drug Trial Hurdles in 2025 Read More »
UK Chancellor Reeves visits China to strengthen economic ties and promote stability amidst UK fiscal concerns. The visit aims to foster cooperation while addressing key issues like human rights and the war in Ukraine.
UK Chancellor Reeves Seeks Economic Stability and Cooperation in China Visit Read More »
US economy shows surprising strength, defying slowdown predictions. Jobless claims fell, GDP growth was revised upward, and consumer spending remains robust, despite the Fed’s rate cut.
US Economy Shows Resilience Amidst Fed Rate Cuts and Projected Slowdown Read More »
Trump’s potential return sparks debate over US banking regulation, including proposals to dismantle the CFPB and potentially abolish the FDIC. These changes could lead to less scrutiny and fewer rules for banks, impacting financial stability and consumer protection.
Proposed US Banking Regulation Overhaul Under Trump Administration Read More »
ECB cuts key interest rate to 3% amid slowing eurozone growth and political uncertainty. The move aims to stimulate economic activity as inflation nears the 2% target and concerns rise about trade and political instability.
ECB Cuts Rates Amidst Weakening Growth and Political Uncertainty Read More »
Ripple CEO created Fairshake Super PAC to counter SEC’s “war on crypto,” spending $40M+ in the 2024 election. This follows an ongoing legal battle between Ripple and the SEC over XRP’s classification.
Garlinghouse: Fairshake Super PAC a Response to SEC’s “War on Crypto” Read More »
CagriSema, Novo Nordisk’s experimental weight-loss drug, falls short of its 25% weight loss target in trials, impacting stock prices. Despite this, a significant portion of participants achieved substantial weight loss, leaving future potential still uncertain.
Novo Nordisk’s Ozempic Successor, CagriSema, Falls Short of Weight Loss Expectations Read More »
Brazil’s central bank confirmed two 100 basis point rate hikes are likely, despite investor expectations of more aggressive action. This reinforces the bank’s commitment to controlling inflation amid economic growth and fiscal concerns.
Brazil Central Bank Signals Commitment to Two 100 Basis Point Rate Hikes Read More »
Markets plunged after the Fed cut rates but signaled fewer cuts than expected in 2025, citing higher inflation and growth projections. The Dow fell over 1,000 points, marking its longest losing streak since 1974, with tech stocks also tumbling.
Market Plunges as Fed Signals Fewer Rate Cuts in 2025 Read More »
Scotiabank gains Fed approval to acquire a 14.99% stake in KeyCorp, marking a strategic shift to North American markets. This $2.8B investment offers growth potential and aligns with the bank’s focus on developed economies.
Scotiabank Granted Fed Approval to Acquire Stake in KeyCorp Read More »
